X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
female (43) 43
index medicus (39) 39
male (37) 37
middle aged (32) 32
aged (30) 30
adult (21) 21
treatment outcome (18) 18
oncology (17) 17
risk (15) 15
chemotherapy (14) 14
statistics & probability (14) 14
japan (13) 13
epidemiology (12) 12
medicine, research & experimental (12) 12
clinical trials (11) 11
risk factors (11) 11
survival rate (11) 11
models, statistical (10) 10
mortality (10) 10
public health (10) 10
public, environmental & occupational health (10) 10
confidence intervals (9) 9
japan - epidemiology (9) 9
surgery (9) 9
survival analysis (9) 9
cancer (8) 8
case-control studies (8) 8
cohort studies (8) 8
incidence (8) 8
odds ratio (8) 8
prospective studies (8) 8
survival (8) 8
analysis (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
epidemiologic methods (7) 7
gastroenterology & hepatology (7) 7
hypertension - drug therapy (7) 7
medicine & public health (7) 7
patients (7) 7
prognosis (7) 7
therapy (7) 7
aged, 80 and over (6) 6
carcinoma (6) 6
cardiac & cardiovascular systems (6) 6
cisplatin (6) 6
estimators (6) 6
follow-up studies (6) 6
hepatocellular carcinoma (6) 6
medical informatics (6) 6
outcomes (6) 6
research (6) 6
research design (6) 6
respiratory system (6) 6
5-fluorouracil (5) 5
abridged index medicus (5) 5
animals (5) 5
association (5) 5
calcium channel blockers - therapeutic use (5) 5
carcinoma, hepatocellular - therapy (5) 5
care and treatment (5) 5
cisplatin - administration & dosage (5) 5
clinical-trials (5) 5
design (5) 5
disease-free survival (5) 5
drug combinations (5) 5
hypertension (5) 5
liver neoplasms - therapy (5) 5
metaanalysis (5) 5
pancreatic cancer (5) 5
pharmacology & pharmacy (5) 5
time factors (5) 5
2-stage (4) 4
amlodipine - therapeutic use (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - adverse effects (4) 4
benzimidazoles - therapeutic use (4) 4
bias (4) 4
blood pressure - drug effects (4) 4
carcinoma, hepatocellular - mortality (4) 4
combination (4) 4
deoxycytidine - analogs & derivatives (4) 4
environmental sciences (4) 4
exposure (4) 4
health aspects (4) 4
hypertension - mortality (4) 4
identification (4) 4
liver neoplasms - mortality (4) 4
management (4) 4
maximum likelihood estimation (4) 4
medical colleges (4) 4
medicine, general & internal (4) 4
oxonic acid - administration & dosage (4) 4
pancreatic neoplasms - drug therapy (4) 4
pancreatic neoplasms - mortality (4) 4
pancreatic neoplasms - pathology (4) 4
prevalence (4) 4
proportional hazards models (4) 4
radiotherapy (4) 4
randomized controlled trials as topic - methods (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2013, Volume 110, Issue 51, pp. 20569 - 20574
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 163 - 169
Purpose The aim of this trial was to evaluate the efficacy and toxicity of S-1 and concurrent radiation therapy for locally advanced pancreatic cancer (PC).... 
Radiology | Hematology, Oncology and Palliative Medicine | ORAL S-1 | 5-FLUOROURACIL | ONCOLOGY | MAINTENANCE GEMCITABINE | PLUS RADIOTHERAPY | CHEMORADIOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Adenocarcinoma - pathology | Humans | Middle Aged | Male | Antimetabolites, Antineoplastic - administration & dosage | Maintenance Chemotherapy - methods | Carcinoma, Adenosquamous - mortality | Aged, 80 and over | Adult | Dose Fractionation | Female | Pancreatic Neoplasms - mortality | CA-19-9 Antigen - blood | Pancreatic Neoplasms - blood | Chemoradiotherapy - methods | Carcinoma, Adenosquamous - pathology | Drug Administration Schedule | Administration, Oral | Adenocarcinoma - blood | Japan | Pancreatic Neoplasms - pathology | Tegafur - adverse effects | Survival Rate | Oxonic Acid - administration & dosage | Carcinoma, Adenosquamous - blood | Oxonic Acid - adverse effects | Disease-Free Survival | Adenocarcinoma - therapy | Carcinoma, Adenosquamous - therapy | Antimetabolites, Antineoplastic - adverse effects | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Medical colleges | Care and treatment | Nuclear radiation | Pancreatic cancer | Clinical trials | Radiotherapy | Biometry | Public health | Cancer | Index Medicus | IRRADIATION | PATIENTS | CARCINOMAS | PANCREAS | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIATION DOSES | TOXICITY | RADIOTHERAPY | LEUKOPENIA | ANOREXIA | CARBOHYDRATES
Journal Article
Japanese Journal of Biometrics, ISSN 0918-4430, 03/2018, Volume 38, Issue 2, pp. 109 - 115
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2009, Volume 51, Issue 6, pp. 1030 - 1036
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 2/2018, Volume 53, Issue 2, pp. 281 - 290
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 753 - 760
Journal Article
Journal of Critical Care, ISSN 0883-9441, 10/2018, Volume 47, pp. 185 - 191
To determine the proportion of diagnosis and outcomes of critically ill patients with acute kidney injury (AKI), and its association with mortality using the... 
KDIGO | Intensive care | Epidemiology | Acute kidney injury | Sepsis-3 | MORTALITY | CRITERIA | SURGERY | SCORE | ACUTE-RENAL-FAILURE | SEPSIS | RIFLE | CRITICALLY-ILL PATIENTS | ASSOCIATION | AKI | CRITICAL CARE MEDICINE | Septic shock | Prognosis | Diagnosis | Kidney diseases | Mortality
Journal Article
Hypertension, ISSN 0194-911X, 02/2008, Volume 51, Issue 2, pp. 393 - 398
Journal Article
Cancer, ISSN 0008-543X, 04/2015, Volume 121, Issue 7, pp. 1008 - 1016
Journal Article
Journal of Critical Care, ISSN 0883-9441, 06/2019, Volume 51, pp. 229 - 235
Acute kidney injury (AKI) is common in the intensive care unit (ICU). Selected clinical studies have implied human atrial natriuretic peptide (hANP) improves... 
Atrial natriuretic peptide | Dialysis-free survival | Acute kidney injury | Intensive care unit | MORTALITY | MANAGEMENT | PROPENSITY SCORE | RENAL-FUNCTION | INTENSITY | INFUSION | ACUTE HEART-FAILURE | CARDIAC-SURGERY | DISEASE | POLYPEPTIDE | CRITICAL CARE MEDICINE
Journal Article
Journal Article
CANCER MANAGEMENT AND RESEARCH, ISSN 1179-1322, 2019, Volume 11, pp. 3419 - 3432
Purpose: The epithelial to mesenchymal transition (EMT) is pivotal for driving metastasis and recurrence in lung cancer. Some in vitro reports have shown that... 
non-small cell lung cancer | SURVIVAL | TP53 MUTATIONS | CANCER | p53 | EPITHELIAL-MESENCHYMAL TRANSITION | P53 MUTATIONS | statin | survival analysis | ONCOLOGY | MUTANT P53 | RESISTANCE | epithelial to mesenchymal transition | INHIBITORS | SIMVASTATIN | CELL | Medical prognosis | Statins | Mutation
Journal Article